Cliff Asness’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.8M Sell
1,245,588
-2,205,038
-64% -$26.4M 0.01% 1265
2026
Q1
$20.2M Sell
3,450,626
-5,120,332
-60% -$38.5M 0.01% 1028
2025
Q4
$61.3M Buy
8,570,958
+4,394,814
+105% +$34.7M 0.03% 618
2025
Q3
$43.6M Buy
4,176,144
+921,260
+28% +$9.04M 0.03% 641
2025
Q2
$31.5M Buy
3,254,884
+1,876,264
+136% +$19.4M 0.03% 673
2025
Q1
$19.9M Sell
1,378,620
-63,535
-4% -$977K 0.02% 701
2024
Q4
$21.3M Sell
1,442,155
-1,032,535
-42% -$16.8M 0.03% 617
2024
Q3
$47.3M Sell
2,474,690
-998,965
-29% -$20.7M 0.07% 392
2024
Q2
$71.9M Buy
3,473,655
+988,336
+40% +$19.6M 0.11% 225
2024
Q1
$46.5M Buy
2,485,319
+160,649
+7% +$2.76M 0.08% 305
2023
Q4
$33.5M Buy
2,324,670
+543,221
+30% +$7.39M 0.06% 358
2023
Q3
$30.8M Buy
1,781,449
+173,778
+11% +$3.62M 0.06% 348
2023
Q2
$33.5M Sell
1,607,671
-105,050
-6% -$2.28M 0.07% 321
2023
Q1
$40.1M Buy
1,712,721
+364,726
+27% +$9.79M 0.09% 281
2022
Q4
$37.6M Buy
1,347,995
+260,445
+24% +$6.66M 0.09% 293
2022
Q3
$25.4M Sell
1,087,550
-1,020,856
-48% -$30.8M 0.06% 373
2022
Q2
$71.2M Sell
2,108,406
-1,013,135
-32% -$35.5M 0.16% 167
2022
Q1
$109M Buy
3,121,541
+69,829
+2% +$2.39M 0.21% 107
2021
Q4
$92.9M Buy
3,051,712
+879,847
+41% +$28.7M 0.17% 139
2021
Q3
$71.2M Buy
2,171,865
+1,679,885
+341% +$53.8M 0.13% 186
2021
Q2
$14.9M Buy
+491,980
New +$16.2M 0.03% 585

Other funds holding OGN

Cliff Asness's OGN Position: Q2 2026 in Review

Cliff Asness reduced its Organon & Co (OGN) stake by 64% in Q2 2026, selling an estimated $26.4M and leaving 1,245,588 shares worth $16.8M. The position accounts for 0.01% of the portfolio, ranked #1265.

Cliff Asness first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $109M in Q1 2022. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Cliff Asness held 1,245,588 shares of Organon & Co worth $16.8M as of Q2 2026.
  • Cliff Asness sold 2,205,038 Organon & Co shares in Q2 2026, an estimated $26.4M.
  • Organon & Co made up 0.01% of Cliff Asness's portfolio in Q2 2026, its #1265 holding.
  • Cliff Asness first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • Cliff Asness's Organon & Co position peaked at $109M in Q1 2022.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.